A case of hyperhemolysis syndrome in sickle cell disease and concomitant COVID-19.

导出 OA

翻译打印收藏纠错

第一作者： Allen,Green

第一单位： Department of Pathology, Division of Transfusion Medicine and Hemostasis, University of Texas Southwestern Medical Center, Dallas, TX, USA.

作者： Allen,Green ^[1] ; Heather,Jones ^[1] ; Alecia,Nero ^[2] ; Ibrahim F,Ibrahim ^[2] ; Ravi,Sarode ^[1] ; Lisa M,Scheid ^[3] ; Christopher B,Webb ^[1] ; Brian D,Adkins ^[1] ; Sean G,Yates ^[4]

作者单位： Department of Pathology, Division of Transfusion Medicine and Hemostasis, University of Texas Southwestern Medical Center, Dallas, TX, USA. ^[1] Department of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA. ^[2] Department of Pediatrics, Division of Neonatal-Perinatal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. ^[3] Department of Pathology, Division of Transfusion Medicine and Hemostasis, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: sean.yates@utsouthwestern.edu. ^[4]

关键词 COVID-19 Complement dysregulation Hyperhemolysis syndrome Macrophage activation Phosphatidylserine SARS-CoV-2 Sickle cell disease

主题词男(雄)性(Male);人类(Humans);成年人(Adult);贫血, 镰状细胞性(Anemia, Sickle Cell);溶血(Hemolysis);综合征(Syndrome);血红蛋白类(Hemoglobins)

DOI 10.1016/j.transci.2023.103712

PMID 37149492

发布时间 2023-09-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交